AI Stock Market News Today

Major crypto trade groups and firms are urging the Senate Banking Committee to move forward with the Digital Asset Market Clarity Act following a bipartisan agreement on stablecoin yields. The compromise restricts interest payments that mimic bank deposits while permitting rewards for active transactions.

• Compromise bars stablecoin yield that functions like bank deposits
• Rewards for 'bona fide' transactions remain permitted

Real estate stocks rebounded in April following a period of losses in March. The sector continues to maintain a positive trajectory for the 2026 calendar year.

• Real estate stocks recorded gains in April
• Sector recovered from losses sustained in March

Industry experts are cautioning Bitcoin holders against a proposed eCash fork, labeling it a hazardous airdrop rather than a legitimate network split. The project faces criticism over its security protocols and the redistribution of dormant coins.

• Developers label the eCash fork as a 'hazardous airdrop' rather than a true network split
• Lack of replay protection could lead to accidental fund loss across chains

SVP Joe Clark reduced his direct holdings in Penguin Solutions by approximately 7% through open-market sales. The transaction occurs as the company raises its annual sales growth forecast due to surging AI infrastructure demand.

• Insider sale of 6,485 shares at $29.26 average price
• Executive retains 86,776 shares post-transaction

Average 401(k) balances for millennials stand at $80,700, highlighting a significant funding gap compared to Gen X and Baby Boomers. The data underscores a growing need for supplemental savings to ensure retirement security.

• Millennial average 401(k) balance is $80,700
• Gen X average balance is $217,500

Twelve of fifteen S&P 500 consumer discretionary companies exceeded earnings per share expectations this week. The results highlight fundamental resilience within the sector despite broader market pressures.

• 12 out of 15 S&P 500 consumer discretionary firms beat EPS estimates
• Results indicate fundamental resilience in consumer spending

AI developer Anthropic is reportedly in discussions to procure inference chips from UK startup Fractile. The move aims to enhance the operational efficiency of running large-scale AI models.

• Anthropic in talks with UK startup Fractile for AI chips
• Focus on inference-specific hardware to increase efficiency

Engineering giant Fluor has fully exited its equity position in NuScale Power to strengthen its balance sheet. The company will transition to a preferred EPC partner role while utilizing the windfall for debt reduction and share buybacks.

• Full exit of 126 million shares in NuScale Power
• Gross proceeds of $2.43 billion realized

Regeneron Pharmaceuticals posted a 19% increase in first-quarter revenue, bolstered by strong sales of Dupixent and Libtayo. The company also secured FDA approval for its first gene therapy for hearing loss, Otarmeni.

• Q1 revenue reached $3.6 billion, a 19% year-over-year increase
• Adjusted EPS grew 15% to $9.47

American Superconductor (AMSC) saw a significant price rally in April as investors bet on the company's role in supporting AI-driven power grid expansion. Despite strong revenue growth, concerns persist regarding the firm's long-term profitability and margin profile.

• AMSC stock jumped 58.2% in April
• Revenue grew 206% over five years to $280 million

Investment firm Villere St Denis J & Co LLC has reduced its stake in offshore marine support provider Tidewater Inc. by approximately 31%. The divestment follows a significant surge in the company's share price during the first half of 2026.

• Villere St Denis reduced TDW stake by 31% to 292,866 shares
• Divestment followed a 73.9% year-to-date increase in stock price

Axsome Therapeutics saw its shares surge over 20% in April following FDA approval for Auvelity to treat Alzheimer's-related agitation. The drug represents a significant growth catalyst as the first non-antipsychotic option for the condition.

• Auvelity approved for Alzheimer's-related agitation
• Projected market opportunity between $1B and $2B